MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: Comparison of antibiotic susceptibilities between countries and centre types

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue TOPIC T2, 2000, Pages 39-52

  Goossens, H ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BELGIUM; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; CZECH REPUBLIC; DATA ANALYSIS; DRUG ACTIVITY; DRUG POTENCY; DRUG SURVEILLANCE PROGRAM; EUROPE; GERMANY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INTENSIVE CARE UNIT; ITALY; NEUTROPENIA; NONHUMAN; POLAND; RUSSIAN FEDERATION; SWEDEN; SWITZERLAND; TURKEY (REPUBLIC); UNITED KINGDOM;

EID: 0033833328     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.suppl_2.39     Document Type: Article

References (4)

1. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): A global overview
2. Surveillance studies: How can they help the management of infection?
3. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: Resistance implications in the treatment of serious infections